Lee, S., Lee, K., Han, S., Beom, S., Kim, S. Y., Yoo, S. S. (2026). Multiplexed immunohistochemistry (mIHC) analysis and clinical outcomes of nelmastobart in combination with trifluridine/tipiracil and bevacizumab in patients with refractory colorectal cancer (phase 1b/2).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3602